Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Hawaii Health Digest.
Press releases published on August 20, 2025
Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications
GlobeNewswire
·
August 20, 2025
With the Newly Granted IP, the Company’s IP Portfolio for the LIBERTY® System now includes 12 patents granted globally and 57 patent applications pending. The Company Continues to Scale Commercial Readiness Plans for the LIBERTY® System as it Awaits FDA …
Adial Pharmaceuticals Encouraged By U.S. Senate Support for Expanded Clinical Trial Endpoints Beyond Abstinence in Alcohol and Substance Use Disorder Treatments
GlobeNewswire
·
August 20, 2025
GLEN ALLEN, Va., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related …
Autonomix Medical, Inc. Granted New European Patent for First-in-Class Catheter-Based Technology
GlobeNewswire
·
August 20, 2025
Global patent estate encompasses 80 issued patents and 40 pending patent applications Strengthens strategic position in a multi-billion-dollar market opportunity across cardiovascular, renal, and other high-burden diseases THE WOODLANDS, TX, Aug. 20, 2025 …
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Ramón Polo as Senior Vice President, Head of Global Regulatory Affairs
GlobeNewswire
·
August 20, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …
Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share
GlobeNewswire
·
August 20, 2025
WALTHAM, Mass., DUBLIN, Ireland and EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company (“Mural”), and XOMA Royalty Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator …
Phathom Pharmaceuticals Clarifies That There Is No Reduction in Lead Shareholder’s Ownership Following Administrative Change to 13D Filing
GlobeNewswire
·
August 20, 2025
FLORHAM PARK, N.J., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), today clarified that a Schedule 13D filing by Frazier Life Sciences, which is expected to be filed later today, August 20, will include administrative …
genXtraits Inc. and Mendel Biotechnology, Inc. enter collaboration
GlobeNewswire
·
August 20, 2025
ALAMEDA, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- San Francisco Bay Area-based crop biotechnology firms genXtraits, Inc. (genXtraits) and Mendel Biotechnology, Inc. (Mendel) have announced that they have entered a collaboration to develop new crop traits. …
Inspire Medical Systems, Inc. to Present at the Wells Fargo 2025 Healthcare Conference
GlobeNewswire
·
August 20, 2025
MINNEAPOLIS, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive …
AI in Remote Patient Monitoring (RPM) Market to Reach USD 8,438.5 Million by 2030 | MarketsandMarkets™
GlobeNewswire
·
August 20, 2025
Delray Beach, FL, Aug. 20, 2025 (GLOBE NEWSWIRE) -- The global AI in remote patient monitoring market, valued at US$1551.8 million in 2023, stood at US$1,967.7 million in 2024 and is projected to advance at a resilient CAGR of 27.5% from 2024 to 2030, …
Iterum Therapeutics launches ORLYNVAH™, the first and only oral penem antibiotic in the U.S.
GlobeNewswire
·
August 20, 2025
DUBLIN and CHICAGO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and …
BBOT to Participate in Upcoming September Investor Healthcare Conferences
GlobeNewswire
·
August 20, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced that members of its leadership …
Beyond Air Signs New International LungFit PH® Distribution Agreements, Most Notably in Japan
GlobeNewswire
·
August 20, 2025
GARDEN CITY, N.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patient …
Best Day Brewing Adds to Core Brew Lineup with Galaxy Ripple IPA
GlobeNewswire
·
August 20, 2025
SAUSALITO, Calif , Aug. 20, 2025 (GLOBE NEWSWIRE) -- Best Day Brewing, America's fastest-growing non-alcoholic craft beer brand, is excited to announce its fan-favorite Imperial IPA style brew, Galaxy Ripple, is officially joining the brand’s flagship NA …
OneMedNet Adds 2.7M Annual Cardiovascular Studies, Expanding Network
GlobeNewswire
·
August 20, 2025
MINNEAPOLIS, Aug. 20, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet” or the “Company”), a leader in AI-powered Real-World Data (RWD), announced the addition of 85 cardiovascular centers and data sources, expanding its …
BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health
GlobeNewswire
·
August 20, 2025
BURLINGTON, Mass. and JERUSALEM, Aug. 20, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ …
TerrAscend Announces Renewal and Replenishment of $10 Million Share Repurchase Program
GlobeNewswire
·
August 20, 2025
TORONTO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, today announced that its Board of Directors has authorized the Company to renew and replenish …
Anavex Life Sciences Announces New Publication in Medical Journal: Blarcamesine Prevented Cognitive Impairment in Animal Model of Alzheimer’s Disease
GlobeNewswire
·
August 20, 2025
Pre-Treatment with blarcamesine entirely prevented Abeta-induced cognitive decline Confirmed significant biomarker-response in hippocampus NEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a …
Rezolute Appoints Seasoned Commercial Executive Sunil Karnawat as Chief Commercial Officer
GlobeNewswire
·
August 20, 2025
REDWOOD CITY, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism (HI), today announced the appointment of Sunil …
MediWound to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
August 20, 2025
YAVNE, Israel, August 20, 2025 -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that Ofer Gonen, Chief Executive Officer, will participate in a fireside chat, hosted by …
Cytokinetics Names Jim Daly to Board of Directors
GlobeNewswire
·
August 20, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the appointment of James M. Daly to its Board of Directors effective August 19, 2025. Mr. Daly brings over 30 years of global …